- Chris HOBSON, President & CEO di Rare Beauty Brands, Inc.
- Jennifer STANSBURY, Co-Founder and Managing Partner di The Benchmarking Company
- Elsa Navarro Margerita GOMEZ, Skin Unit Director di Khiron Life Sciences Corp.
- Olivia SANTONI, Director di Bloom Regulatory
I prodotti a base di cannabinoidi – CBD - sono ormai ovunque. In tutto il mondo nuovi brand, insieme a quelli già consolidati, si stanno distinguendo grazie a idee innovative lanciando prodotti medicali e beauty, integratori, cibo e bevande. Le opportunità offerte dal mercato di prodotti contenenti CBD derivata dalla cannabis sono però legate a una diffusa confusione legale. "È legale o no?", “Quali rischi e quali benefici ha questo ingrediente?” sono le domande più diffuse rispetto a questi prodotti. Questo convegno riunisce un panel di esperti di questo mercato. Insieme a loro scopriremo le possibilità di sviluppo, le modalità di produzione, la corretta distribuzione e le strategie di marketing più idonee per il successo di questo tipo di prodotti.
Chris Hobson is the President & CEO of Rare Beauty Brands, Inc., an operating company that incubates, acquires and scales high potential independent beauty brands. The company began by building Patchology from an idea into one of the fastest growing, most awarded beauty brands in the world and is in the process of adding several new brands to its portfolio. Hobson leverages his experience and network from his time as in brand management at Procter & Gamble, in addition to his executive roles at several entrepreneurial ventures. He earned his BA at McGill University and his MBA at Harvard Business School.
HOBSON President & CEO di Rare Beauty Brands, Inc.
Jennifer is the co-Founder of The Benchmarking Company, a beauty and personal care research firm that that is laser-focused on providing quantitative and qualitative consumer research. TBC has a proven track record in cosmetics, skincare, beauty devices, men’s personal care, body care, nail care, fragrance and wellness and personal care. Jennifer has worked for more than 25 years as a marketing, communications and research professional, successfully implementing effective marketing strategies to grow market share for companies in many industries. Additionally, Jennifer conducts research for the PinkReports™ - an annual deep-dive, extensive report into an industry trend. Through this research, Jennifer has become an expert in topics including: natural and organic beauty and personal care, consumer’s demand and acceptance of CBD/cannabis-based products, retail specific shopping behaviors and forecasting beauty trends to name a few. Jennifer serves on the board of directors of ICMAD and is a member of CEW and Beauty Industry West.
STANSBURY Co-Founder and Managing Partner di The Benchmarking Company
International Business Administrator from Sabana University, with 10 years of professional experience in developing and executing marketing and sales strategies in multiple industries: Dermocosmetics Attraction of foreign investment, agro-industry, bio-fuel, events and food & beverages companies. Currently she is Skin Director at Khiron Life Sciences Corp., leading the first cosmeceutical brand with cannabis that was launched on October 2018 in Colombia. Establishing creative and innovative marketing, sales and communication strategies to reach consumers and educate them about the skin benefits of this new ingredient, cannabis. Opening both national and international markets and building relationships with strategic partners.
Elsa Navarro Margerita
GOMEZ Skin Unit Director di Khiron Life Sciences Corp.
Olivia Santoni is the founder of Bloom Regulatory Ltd, which provide s regulatory intelligence, EU/UK and International compliance advice, and high quality regulatory strategy services to the cosmetics industry. Olivia has worked in collaboration with key stakeholders on regulatory topics to advocate for the needs of the cosmetics industry to key stakeholders such as the UK Government, the EU Commission and non-EU authorities. Olivia has been working in collaboration with the industry, the UK Government and the EU Commission on the topic of CBD, in particular regarding borderline issues, claims substantiations and ingredient status to provide legal and regulatory clarifications to the industry. Priori to Bloom, Olivia was Director, Regulatory and International Services at CTPA managing the Regulatory and International team and leading the Association’s work on the EU Cosmetics Regulation, REACH, borderlines, claims management and the impact of Brexit on the cosmetics industry. She also worked for the French “Agence Nationale de Sécurité du Médicament et des Produits de Santé” (ANSM) in the medical devices regulatory and inspection department and was part of the international department of the French cosmetics trade association (FEBEA) advising members on international regulatory issues. She studied law at the University of Paris Rene Descartes specialising in Business Law and Health Product Law.
SANTONI Director di Bloom Regulatory